For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221220:nRST2291Ka&default-theme=true
RNS Number : 2291K Induction Healthcare Group PLC 20 December 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Change of Auditor
Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that following a
competitive and comprehensive tender process, Crowe U.K. LLP will be appointed
as the Company's auditor for the year ending 31 March 2023. The Company
intends to put the appointment of Crowe U.K. LLP as auditor to a vote of
shareholders at the Company's next Annual General Meeting.
KPMG LLP, the Company's current auditor, will cease to hold office as the
Group's auditor when the present term of office expires at the conclusion of
the Company's 2023 AGM. KPMG LLP has confirmed that there are no matters
connected with it ceasing to hold office that should be brought to the
attention of the members or creditors of the Company.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Christopher Samler, Non-Executive Chair
Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com
Alice Woodings / Paul McManus Mob: +44 (0)7407 804 654 / +44(0)7980 541 893
About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)
Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END APPZZMMZNLKGZZM